Firebrick Pharma
Manufacturing · Australia · 1-10 Employees
View Company Info for Free
Overview
Headquarters
440 Collins St, Melbourne, Victoria, 300...Phone Number
+61 1300301874Website
www.firebrickpharma.comRevenue
<$5 MillionStock Symbol
FREIndustry
About Firebrick Pharma
Firebrick Pharma Org Chart
Is Firebrick Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Firebrick Pharma has new funding data
Firebrick Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Firebrick Pharma recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check if Firebrick Pharma has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Firebrick Pharma launches new products
Check out if Firebrick Pharma is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Firebrick Pharma
Click to see if Firebrick Pharma had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Firebrick Pharma
Compare insights from companies similar to Firebrick Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Firebrick Pharma
Company Profile Activity
Activity Insights
Firebrick Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Firebrick Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Firebrick Pharma.
Firebrick Pharma Tech Stack
A closer look at the technologies used by Firebrick Pharma
Firebrick Pharma News & Media
Firebrick Pharma First Half 2023 Earnings: AU$0.019 loss per share (vs AU$0.013 loss in 1H 2022)
Firebrick Pharma ( ASX:FRE ) First Half 2023 Results Key Financial Results Net loss: AU$3.13m (loss widened by 103...Is Firebrick Pharma (ASX:FRE) In A Good Position To Invest In Growth?
Just because a business does not make any money, does not mean that the stock will go down. For example, although...We're Not Very Worried About Firebrick Pharma's (ASX:FRE) Cash Burn Rate
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...Proactive news headlines including Belararox, Elementos, Firebrick Pharma and First Graphene
Sydney, Jan. 28, 2022 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies: Belararox Ltd has floated on the Australian Stock Exchange under the ticker ‘BRX’, positioning itself as a technology and renewable energy base and precious metal explorer with potential exposure to zinc, copper, gold, silver, nickel and lead. Click hereElementos Ltd (ASX:ELT, OTC:ELTLF) has maintained its buy rating fr
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Firebrick Pharma
Firebrick Pharma is an Australian pharmaceutical innovator founded in 2012 with a focus on developing novel formulations for use in the nose. The company is dedicated to providing pharmaceutical solutions through the use of unique povidone-iodine formulations. Firebrick Pharma aims to cater to individuals seeking innovative pharmaceutical products... Read More